AU3514199A - Novel therapy for treatment of lysosomal storage disease - Google Patents

Novel therapy for treatment of lysosomal storage disease

Info

Publication number
AU3514199A
AU3514199A AU35141/99A AU3514199A AU3514199A AU 3514199 A AU3514199 A AU 3514199A AU 35141/99 A AU35141/99 A AU 35141/99A AU 3514199 A AU3514199 A AU 3514199A AU 3514199 A AU3514199 A AU 3514199A
Authority
AU
Australia
Prior art keywords
treatment
lysosomal storage
storage disease
novel therapy
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35141/99A
Inventor
Patricia L. Chang
Martin R. Ralph
Colin J. D. Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3514199A publication Critical patent/AU3514199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU35141/99A 1998-05-06 1999-05-06 Novel therapy for treatment of lysosomal storage disease Abandoned AU3514199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002236989A CA2236989A1 (en) 1998-05-06 1998-05-06 Novel therapy for treatment of lysosomal storage disease
CA2236989 1998-05-06
PCT/CA1999/000368 WO1999056770A2 (en) 1998-05-06 1999-05-06 Novel therapy for treatment of lysosomal storage disease

Publications (1)

Publication Number Publication Date
AU3514199A true AU3514199A (en) 1999-11-23

Family

ID=4162400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35141/99A Abandoned AU3514199A (en) 1998-05-06 1999-05-06 Novel therapy for treatment of lysosomal storage disease

Country Status (3)

Country Link
AU (1) AU3514199A (en)
CA (1) CA2236989A1 (en)
WO (1) WO1999056770A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122177B2 (en) 2000-01-20 2006-10-17 Diabcell Pty Ltd. Preparation and xenotransplantation of porcine islets

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543390A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting

Also Published As

Publication number Publication date
WO1999056770A3 (en) 2000-01-13
WO1999056770A2 (en) 1999-11-11
CA2236989A1 (en) 1999-11-06

Similar Documents

Publication Publication Date Title
AU9028798A (en) Method of improving drug treatment
AU5032500A (en) Treatment of irregular ventricular contractions
AU3891299A (en) Combination therapy for treatment of depression
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU1087401A (en) Metalloporphyrin treatment of neurologic disease
AU2508597A (en) Drug for the treatment of tumours
AU3784999A (en) Methods for treatment of pain
AU2001236713A1 (en) Methods for treatment of lysosomal storage diseases
AU3896900A (en) Treatment of pain
AU3082401A (en) Therapy of psoriasis
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU1878201A (en) Composition for the treatment of damaged tissue
AU7106300A (en) Treatment of skin disorders
AU7636800A (en) Improved ricin-like toxins for treatment of cancer
AU4443599A (en) Therapeutic bed
AUPP870999A0 (en) Method of treatment of equine disease
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU3760900A (en) Treatment of menstrual function
AU2566201A (en) Compounds and methods for the treatment of pain
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU1940800A (en) Combination therapy for the treatment of sepsis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase